Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Biomaterials. 2009 Jul 31;30(29):5649–5659. doi: 10.1016/j.biomaterials.2009.05.068

Fig. 1.

Fig. 1

Schematic representation of a monodisperse biodegradable dimeric nanocarrier composed of peptidic backbone irreversibly or reversibly conjugated with one or more targeting ligand/drug either directly or through the distal ends of PEG.